CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
73,574,718
Share change
+6,866,097
Total reported value
$171,419,210
Put/Call ratio
57%
Price per share
$2.33
Number of holders
123
Value change
+$15,161,544
Number of buys
51
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q1 2018

As of 31 Mar 2018, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 123 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,574,718 shares. The largest 10 holders included BlackRock Inc., AMERIPRISE FINANCIAL INC, KLP Enterprises, LLC, Meditor Group Ltd, VANGUARD GROUP INC, FMR LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, and MILLENNIUM MANAGEMENT LLC. This page lists 123 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.